DK1553178T3 - Onkolytisk virus til selektiv vækst i tumorceller - Google Patents

Onkolytisk virus til selektiv vækst i tumorceller

Info

Publication number
DK1553178T3
DK1553178T3 DK03741222.8T DK03741222T DK1553178T3 DK 1553178 T3 DK1553178 T3 DK 1553178T3 DK 03741222 T DK03741222 T DK 03741222T DK 1553178 T3 DK1553178 T3 DK 1553178T3
Authority
DK
Denmark
Prior art keywords
tumor cells
selective growth
oncolytic virus
oncolytic
virus
Prior art date
Application number
DK03741222.8T
Other languages
English (en)
Inventor
Yoshiko Shirakiya
Satoru Kyo
Toshiyoshi Fujiwara
Noriaki Tanaka
Takeshi Kawashima
Original Assignee
Oncolys Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolys Biopharma Inc filed Critical Oncolys Biopharma Inc
Application granted granted Critical
Publication of DK1553178T3 publication Critical patent/DK1553178T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK03741222.8T 2002-07-08 2003-07-07 Onkolytisk virus til selektiv vækst i tumorceller DK1553178T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002198941A JP3867968B2 (ja) 2002-07-08 2002-07-08 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス
PCT/JP2003/008573 WO2004005511A1 (ja) 2002-07-08 2003-07-07 腫瘍細胞において選択的に増殖する腫瘍融解ウイルス

Publications (1)

Publication Number Publication Date
DK1553178T3 true DK1553178T3 (da) 2014-05-19

Family

ID=30112441

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03741222.8T DK1553178T3 (da) 2002-07-08 2003-07-07 Onkolytisk virus til selektiv vækst i tumorceller

Country Status (15)

Country Link
US (1) US20060239967A1 (da)
EP (1) EP1553178B1 (da)
JP (1) JP3867968B2 (da)
KR (2) KR20050075867A (da)
CN (1) CN100430476C (da)
AU (1) AU2003281310B2 (da)
CA (1) CA2491907C (da)
DK (1) DK1553178T3 (da)
ES (1) ES2455127T3 (da)
HK (1) HK1082958A1 (da)
NZ (1) NZ537631A (da)
PL (1) PL374644A1 (da)
PT (1) PT1553178E (da)
WO (1) WO2004005511A1 (da)
ZA (1) ZA200500047B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473418B2 (en) * 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
EP1745801A1 (en) * 2004-05-13 2007-01-24 Daiichi Pharmaceutical Co., Ltd. Method of inhibiting telomerase activity and inhibitor
CN100361710C (zh) * 2004-06-07 2008-01-16 成都康弘生物科技有限公司 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用
US7943373B2 (en) * 2004-09-29 2011-05-17 Oncolys Biopharma, Inc. Telomelysin/GFP-expressing recombinant virus
JPWO2006085689A1 (ja) * 2005-02-10 2008-06-26 オンコリスバイオファーマ株式会社 テロメライシン併用抗癌剤
JP5069871B2 (ja) * 2006-05-30 2012-11-07 シスメックス株式会社 新規な癌細胞検出試料調製用キット及びそれを用いた癌細胞検出用キット
WO2008065726A1 (fr) * 2006-11-29 2008-06-05 Oncolys Biopharma Inc. Agent contenant du télomelysin destiné à rompre la tolérance anti-tumorale
JP5580043B2 (ja) * 2007-04-27 2014-08-27 オンコリスバイオファーマ株式会社 放射線増感増強剤
US20090181931A1 (en) * 2008-01-16 2009-07-16 Oncolys Biopharma, Inc. Antiviral activity of cidofovir against oncolytic viruses
US20110250588A1 (en) 2008-12-18 2011-10-13 Sysmex Corporation Method for detecting cancer cells in blood sample
US9645154B2 (en) 2010-12-24 2017-05-09 Arkray, Inc. Method for detecting cancer cell
CN106591368A (zh) * 2016-10-12 2017-04-26 郑州大学 携带il‑15r/il‑15融合基因的b亚群腺病毒11载体及其构建和用途
EP3695846B1 (en) 2017-10-10 2023-11-29 Yamaguchi University Enhancer for t-cells or b-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in t-cells or b-cells
CN113993531A (zh) * 2019-05-14 2022-01-28 癌康理生物制药株式会社 向肿瘤组织施加溶瘤病毒的方法以及施加用装置
TW202130656A (zh) 2019-10-28 2021-08-16 日商諾伊爾免疫生物科技股份有限公司 用以治療癌症的醫藥、組合醫藥、醫藥組成物、免疫反應性細胞、核酸輸送媒體、及製品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1275299A (en) * 1997-10-23 1999-05-10 Uab Research Foundation Human papillomavirus vectors for the episomal transduction of host cells and method of making same
EP1147181B1 (en) * 1999-02-04 2004-05-12 Geron Corporation Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
US6692736B2 (en) * 2000-03-24 2004-02-17 Cell Genesys, Inc. Cell-specific adenovirus vectors comprising an internal ribosome entry site
AU4764801A (en) * 2000-03-24 2001-10-08 Calydon Inc Cell-specific adenovirus vectors comprising an internal ribosome entry site
IL152420A0 (en) * 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
CN1177042C (zh) * 2001-04-12 2004-11-24 上海华康生物技术有限公司 共表达人p53基因和人细胞因子基因的重组腺病毒及其制法和用途
CN1195056C (zh) * 2001-07-12 2005-03-30 钱其军 一种在肿瘤细胞中特异性增殖及高效表达抗癌基因的重组病毒及其构建方法

Also Published As

Publication number Publication date
KR100947194B1 (ko) 2010-03-11
PL374644A1 (en) 2005-10-31
CA2491907A1 (en) 2004-01-15
ES2455127T3 (es) 2014-04-14
JP3867968B2 (ja) 2007-01-17
CA2491907C (en) 2013-03-19
AU2003281310B2 (en) 2008-02-21
CN100430476C (zh) 2008-11-05
CN1665927A (zh) 2005-09-07
ZA200500047B (en) 2006-05-31
JP2004033186A (ja) 2004-02-05
AU2003281310A1 (en) 2004-01-23
PT1553178E (pt) 2014-06-12
NZ537631A (en) 2007-05-31
EP1553178A4 (en) 2006-03-29
KR20090043589A (ko) 2009-05-06
EP1553178B1 (en) 2014-03-05
KR20050075867A (ko) 2005-07-22
US20060239967A1 (en) 2006-10-26
WO2004005511A1 (ja) 2004-01-15
EP1553178A1 (en) 2005-07-13
HK1082958A1 (en) 2006-06-23

Similar Documents

Publication Publication Date Title
HK1082958A1 (en) Tumor-lysing virus growing selectively in tumor cells
IS7992A (is) Dýralaus frumuræktunar aðferð
DE60330151D1 (de) Brennstoffzellensystem
DE60334419D1 (de) Photovoltaische Zelle
DE60316596D1 (de) Brennstoffzellensystem
DE10324396A8 (de) Brennstoffzelle
DE60330541D1 (de) System zum Verfolgen von Poststücken
DE60313336D1 (de) Antennengruppe mit virtuellen antennenelementen und zugehörige methode
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
DE60331474D1 (de) Brennstoffzellensystem
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
DE50313510D1 (de) Zellkultureinsatz
DE60331959D1 (de) Brennstoffzellensystem
DE60329024D1 (de) Brennstoffzelle
DE602004023025D1 (de) Brennstoffzellenanlage mit Wasseraufbereitung
DE60303345D1 (de) Brennstoffzelle
DE60321289D1 (de) Brennstoffzellensystem
DE60304884D1 (de) Segmentierte reifenform zur verringerung von grat
DE60323022D1 (de) Brennstoffzelle
DE10393666D2 (de) Leistungsgeregelte Brennstoffzelle
DE60312367D1 (de) Brennstoffzellensystem
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
NO20033082L (no) Enkeltcelleproteinmateriale
ES1053078Y (es) Celula fotovoltaica de lupa multiple y escalonada en orden decreciente de lupas.
ATE417234T1 (de) Solaranlage